Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1991-4-24
|
pubmed:abstractText |
Current evidence suggests that the development of allosensitized cytotoxic T lymphocytes within sponge matrix allografts takes place primarily in situ and may be regulated by the secretory products of the cells infiltrating the graft. In vitro studies have implicated IL-2, IL-4, and IL-6 in CTL development. We have reported that TNF-alpha, macrophage colony-stimulating factor, IL-1, IFN-alpha, and IFN-beta are present in the allograft, but that IL-2 and IL-4 cannot be detected at any time using specific bioassays. In this study, we found significantly higher levels of IL-6 within the allografts compared with the syngeneic grafts. Peak IL-6 activity coincided with the appearance of allosensitized CTL in the allografts. IL-6 concentration in the serum of sponge allografted mice was less than 1% of that found in the graft. The sponge fluid exhibited both hybridoma growth factor and hepatocyte-stimulating factor activities in vitro, and both these activities were neutralized by antibody to murine IL-6 but not by antibody to murine IL-1-beta or TNF-alpha. Messenger RNA for murine IL-6 was detected in the graft-infiltrating cells. The high level of IL-6 found in the allograft coincident with the appearance of cellular immunity suggests that this cytokine might play some role in the development of allospecific CTL in vivo.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0041-1337
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
51
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
656-61
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:2006523-Animals,
pubmed-meshheading:2006523-Antibodies,
pubmed-meshheading:2006523-Female,
pubmed-meshheading:2006523-Graft Rejection,
pubmed-meshheading:2006523-Immunity, Cellular,
pubmed-meshheading:2006523-Interleukin-6,
pubmed-meshheading:2006523-Mice,
pubmed-meshheading:2006523-Mice, Inbred BALB C,
pubmed-meshheading:2006523-Mice, Inbred C57BL,
pubmed-meshheading:2006523-Mice, Inbred Strains,
pubmed-meshheading:2006523-Neutralization Tests,
pubmed-meshheading:2006523-RNA, Messenger,
pubmed-meshheading:2006523-T-Lymphocytes, Cytotoxic,
pubmed-meshheading:2006523-Transplantation, Homologous
|
pubmed:year |
1991
|
pubmed:articleTitle |
Evidence that production of interleukin 6 within the rejecting allograft coincides with cytotoxic T lymphocyte development.
|
pubmed:affiliation |
Department of Surgery, University of Pittsburgh, Pennsylvania.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|